Andrew Einhorn
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Einhorn
Andrew Einhorn was last confirmed as CFO at Cognition Therapeutics Inc (CGTX) in a filing dated April 24, 2023. Cognition Therapeutics Inc reported in an 8-K filed July 27, 2022 that Andrew Einhorn was appointed Interim Chief Financial Officer, effective August 12, 2022. The proxy statement of Cognition Therapeutics Inc reports total compensation of $319,450 for Andrew Einhorn in fiscal 2022, including a base salary of $319,450. Andrew Einhorn has spoken on 1 earnings call across 1 company, most recently for Cognition Therapeutics Inc on March 23, 2023.
“On July 25, 2022, the board of directors of the Company appointed Andrew Einhorn as Interim Chief Financial Officer, effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-04-24
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Cognition Therapeutics Inc (CGTX) | Interim Chief Financial Officer | $319,450 | $319,450 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.